Global Information
회사소개 | 문의

세계의 의약품-의료기기 병용 제품 시장(2017-2027년)

Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches

리서치사 Visiongain Ltd
발행일 2017년 08월 상품 코드 562115
페이지 정보 영문 151 Pages
가격
£ 2,699 ₩ 4,035,000 Unprintable PDF (Single User) - 1 Year License help
1명만 이용할 수 있는 라이센스입니다. DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 인증된 PC 1대에서만 열람이 가능하며, 구입일로부터 1년간 유효합니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄 또한 불가능합니다.
£ 2,999 ₩ 4,483,500 PDF (Departmental - 5 Users) - 1 Year License help
동일 사업장(소재지) 내 5명까지 이용할 수 있는 라이센스입니다. DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 인증된 PC에서만 열람이 가능하며, 구입일로부터 1년간 유효합니다. PDF파일은 Copy & Paste가 되지 않으며, 인쇄는 1명당 1회에 한해 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
£ 4,999 ₩ 7,473,500 PDF (Site License) help
동일 사업장(소재지) 내 모든 분이 이용할 수 있는 라이센스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 되지 않습니다. DRM(디지털 저작권 관리시스템)은 적용되어 있지 않지만, PDF 인쇄는 1명당 1회에 한해 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
£ 6,999 ₩ 10,463,500 PDF (Global Site License - Includes Free Datasets) help
동일 기업의 전세계 분들이 이용할 수 있는 라이센스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste 가 되지 않습니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 의약품-의료기기 병용 제품 시장(2017-2027년) Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches
발행일 : 2017년 08월 페이지 정보 : 영문 151 Pages

한글목차

세계의 의약품-의료기기 병용 제품 시장 규모는 2016년에 1,370억 달러를 기록했으며, 예측기간의 전반기에는 6.2%의 연평균 성장률(CAGR)로 성장할 전망입니다. 2016년에 경점막 제품 부문은 21%의 점유율을 차지해 시장의 대부분을 구성했습니다.

세계의 의약품-의료기기 병용 제품(Drug-Device Combination) 시장에 대해 조사 분석했으며, 시장 개요, 최종사용자·제품·지역별 시장 예측, 주요 지역 시장 분석, 시장 영향요인 분석, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 조사 개요

제2장 의약품-의료기기 병용 제품 시장의 정의

  • 의약품-의료기기 병용 제품이란?
  • 의약품-의료기기 병용 제품의 종류
    • 약물용출스텐트(DES)
    • 광증감제
    • 정형외과 제품
    • 주입 펌프
    • 창상관리 제품
    • 경점막 제품
    • 경피 제품
  • 의약품-의료기기 병용 제품 시장 구조
  • 의약품-의료기기 병용 제품 시장 분류

제3장 세계의 의약품-의료기기 병용 제품 시장 : 최종사용자별

  • 병원 및 진료소 시장 예측과 분석
  • 응급 서비스 센터 시장 예측과 분석
  • 외래 외과 센터 시장 예측과 분석
  • 재택 의료 시장 예측과 분석

제4장 세계의 의약품-의료기기 병용 제품 시장 : 제품별

  • 약물용출스텐트(DES) 시장 예측과 분석
  • 광증감제 시장 예측과 분석
  • 정형외과 제품 시장 예측과 분석
  • 주입 펌프 시장 예측과 분석
  • 창상관리 제품 시장 예측과 분석
  • 경점막 제품 시장 예측과 분석
  • 경피 제품 시장 예측과 분석
  • 기타 시장 예측과 분석

제5장 지역의 의약품-의료기기 병용 제품 시장 예측

  • 지역의 의약품-의료기기 병용 제품 시장 예측
  • 북미의 의약품-의료기기 병용 제품 시장 예측
  • 북미의 의약품-의료기기 병용 제품 시장 예측 : 제품별
  • 북미의 의약품-의료기기 병용 제품 시장 예측 : 최종사용자별
  • 유럽의 의약품-의료기기 병용 제품 시장 예측
  • 유럽의 의약품-의료기기 병용 제품 시장 예측 : 제품별
  • 유럽의 의약품-의료기기 병용 제품 시장 예측 : 최종사용자별
  • 아시아태평양의 의약품-의료기기 병용 제품 시장 예측
  • 아시아태평양의 의약품-의료기기 병용 제품 시장 예측 : 제품별
  • 아시아태평양의 의약품-의료기기 병용 제품 시장 예측 : 최종사용자별
  • 기타 지역(RoW)의 의약품-의료기기 병용 제품 시장 예측

제6장 성장 촉진요인과 억제요인

  • 성장 촉진요인과 억제요인
  • 성장 촉진요인
  • 성장 억제요인

제7장 의약품-의료기기 병용 제품 시장의 주요 기업

  • Medtronic
  • Boston Scientific Corporation
  • Stryker Corporation
  • Ethicon Inc.
  • C. R. Bard Inc.
  • Medline Industries Inc.
  • Mylan Inc.
  • Terumo Corporation
  • Pinnacle Biologics Inc.
  • W.L. Gore & Associates Inc.

제8장 의약품-의료기기 병용 제품 시장의 정성 분석

제9장 결론

  • 현재 주요 부문

부록

도표

KSM 17.10.17

영문목차

The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 151 page report you will receive 124 charts - all unavailable elsewhere.

The 151-page report provides clear detailed insight into the global drug-device combination market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Drug-Device Combination Market forecasts from 2017-2027
  • Revenue forecast for the drug-device combination market by End-Users:
    • Hospitals & clinics
    • Emergency service centers
    • Ambulatory surgical centers
    • Home care settings

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

  • Revenue forecast for the drug-device combination market by Products:
    • Drug eluting stents
    • Photosensitizers
    • Orthopaedic products
    • Infusion pumps
    • Wound care products
    • Transmucosal products
    • Transdermal patches
    • Others

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

  • This report provides individual revenue forecasts from 2017-2027 for these regional and national markets:
    • North America: The U.S and Rest of North America
    • Europe: France, Germany, Italy, U.K, Spain, Russia and Rest of Europe
    • Asia-Pacific: China, India, Japan, and Rest of Asia-Pacific countries
    • Rest of the world (RoW) : Latin America, and Middle East and African countries

image1

Each regional market is further divided by end-users and products

  • This report discusses the leading companies in the global drug-device combination market:
    • Medtronic
    • Boston Scientific Corporation
    • Stryker Corporation
    • Ethicon Inc
    • C.R. Bard Inc.
    • Medline Industries Inc.
    • Mylan Inc.
    • Terumo Corporation
    • Pinnacle Biologics Inc.
    • W. L. Gore & Associates, Inc.
  • This report discusses the drivers, restraints as well as porter's five forces analysis of the global drug-device combination market

Visiongain's study is intended for anyone requiring commercial analyses for the global drug-device combination market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global Drug-Device Combination Market Overview
  • 1.2 Why You Should Read This Report
  • 1.3 Key Questions Answered by This Analytical Report
  • 1.4 Who is This Report For?
  • 1.5 Methodology
  • 1.6 Frequently Asked Questions (FAQ)
  • 1.7 Associated Visiongain Reports
  • 1.8 About Visiongain

2. Drug-Device Combination Market Definition

  • 2.1 What are Drug-Device Combination Products?
  • 2.2 Types of Drug-Device Combination Products
    • 2.2.1 Drug Eluting Stents
    • 2.2.2 Photosensitizers
    • 2.2.3 Orthopedic Products
    • 2.2.4 Infusion Pumps
    • 2.2.5 Wound Care Products
    • 2.2.6 Transmucosal Products
    • 2.2.7 Transdermal Products
  • 2.3 Drug-Devices Combination Market Structure
  • 2.4 Classification of Drug-Devices Combination Market

3. Drug-Device Combination Market: Global Market by End-Users 2017-2027

  • 3.1 Hospitals & Clinics Submarket Forecast & Analysis 2017-2027
  • 3.2 Emergency Service Centers Submarket Forecast & Analysis 2017-2027
  • 3.3 Ambulatory Surgical Centers Submarket Forecast & Analysis 2017-2027
  • 3.4 Home Care Settings Submarket Forecast & Analysis 2017-2027

4. Drug-Device Combination: Global Market by Products 2017-2027

  • 4.1 Drug Eluting Stents Submarket Forecast & Analysis 2017-2027
  • 4.2 Photosensitizers Submarket Forecast & Analysis 2017-2027
  • 4.3 Orthopedic Products Submarket Forecast & Analysis 2017-2027
  • 4.4 Infusion Pumps Submarket Forecast & Analysis 2017-2027
  • 4.5 Wound Care Products Submarket Forecast & Analysis 2017-2027
  • 4.6 Transmucosal Products Submarket Forecast & Analysis 2017-2027
  • 4.7 Transdermal Products Submarket Forecast & Analysis 2017-2027
  • 4.8 Other Combination Products Submarket Forecast & Analysis 2017-2027

5. Regional Drug-Device Combination Market Forecasts 2017-2027

  • 5.1 Regional Drug-Device Combination Market Forecasts 2017-2027
  • 5.2 North American Drug-Devices Combination Market Forecasts 2017-2027
    • 5.2.1 U.S. Drug-Devices Combination Market Forecasts 2017-2027
    • 5.2.2 Rest of North America Drug-Device Combination Market Forecasts 2017-2027
  • 5.3 North American Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.4 North American Drug-Device Combination Market Forecasts by End-Users 2017-2027
  • 5.5 Europe Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.1 France Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.2 Germany Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.3 U.K. Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.4 Spain Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.5 Italy Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.6 Russia Drug-Device Combination Market Forecasts 2017-2027
    • 5.5.7 Rest of Europe Drug-Device Combination Market Forecasts 2017-2027
  • 5.6 European Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.7 European Drug-Device Combination Market Forecasts by End-Users 2017-2027
  • 5.8 Asia-Pacific Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.1 China Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.2 India Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.3 Japan Drug-Device Combination Market Forecasts 2017-2027
    • 5.8.4 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts 2017-2027
  • 5.9 Asia-Pacific Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.10 Asia-Pacific Drug-Device Combination Market Forecasts by End-Users 2017-2027
  • 5.11 Rest of the World (RoW) Drug-Device Combination Market Forecasts 2017-2027
    • 5.11.1 Latin America Drug-Device Combination Market Forecasts 2017-2027
    • 5.11.2 Middle East and Africa Drug-Device Combination Market Forecasts 2017-2027
  • 5.12 Rest of the World (RoW) Drug-Device Combination Market Forecasts by Products 2017-2027
  • 5.13 Rest of the World (RoW) Drug-Device Combination Market Forecasts by End-Users 2017-2027

6. Drivers & Restraints

  • 6.1 Drivers and Restraints 2017-2027
  • 6.2 Drivers
    • 6.2.1 Increasing Initiatives by Government and NGO in Support of Drug Delivery Implants
    • 6.2.2 Rising popularity of minimally invasive surgeries
    • 6.2.3 Increasing Prevalence of Chronic Disorders
    • 6.2.4 Technological Innovations and Advancements
  • 6.3 Restraints
    • 6.3.1 Recall of Combination Products Due to Adverse Effects
    • 6.3.2 High Cost of Combination Products
    • 6.3.3 Regulatory and Technical Challenges Pertaining to Combination Products

7. Leading Companies in the Drug-Devices Combination Market

  • 7.1 Medtronic
    • 7.1.1 Medtronic Business Overview
    • 7.1.2 Medtronic Financial Overview
    • 7.1.3 Medtronic Product Portfolio
    • 7.1.4 Medtronic Corporate Strategy
  • 7.2 Boston Scientific Corporation
    • 7.2.1 Boston Scientific Corporation Business Overview
    • 7.2.2 Boston Scientific Corporation Financial Overview
    • 7.2.3 Boston Scientific Corporation Corporate Strategy
    • 7.2.4 Boston Scientific Corporation Product Portfolio
  • 7.3 Stryker Corporation
    • 7.3.1 Stryker Corporation Business Overview
    • 7.3.2 Stryker Corporation Financial Overview
    • 7.3.3 Stryker Corporation Product Portfolio
    • 7.3.4 Stryker Corporation Corporate Strategy
  • 7.4 Ethicon Inc.
    • 7.4.1 Ethicon Inc. Business Overview
    • 7.4.2 Ethicon Inc. Financial Overview
    • 7.4.3 Ethicon Inc. Corporate Strategy
    • 7.4.4 Ethicon Inc. Product Portfolio
  • 7.5 C. R. Bard Inc.
    • 7.5.1 C. R. Bard Inc. Business Overview
    • 7.5.2 C. R. Bard Inc. Financial Overview
    • 7.5.3 C.R. Bard Inc. Corporate Strategy
    • 7.5.4 C.R. Bard Inc. Product Portfolio
  • 7.6 Medline Industries Inc.
    • 7.6.1 Medline Industries Inc. Business Overview
    • 7.6.2 Medline Industries Inc. Financial Overview
    • 7.6.3 Medline Industries Inc. Corporate Strategy
  • 7.7 Mylan Inc.
    • 7.7.1 Mylan Inc. Business Overview
    • 7.7.2 Mylan Inc. Financial Overview
    • 7.7.3 Mylan Inc. Corporate Strategy
    • 7.7.4 Mylan Inc. Product Portfolio
  • 7.8 Terumo Corporation
    • 7.8.1 Terumo Corporation Business Overview
    • 7.8.2 Terumo Corporation Financial Overview
    • 7.8.3 Terumo Corporation Corporate Strategy
    • 7.8.4 Terumo Corporation Product Portfolio
  • 7.9 Pinnacle Biologics Inc.
    • 7.9.1 Pinnacle Biologics Inc. Business Overview
    • 7.9.2 Pinnacle Biologics Inc. Financial Overview
    • 7.9.3 Pinnacle Biologics Corporate Strategy
    • 7.9.4 Pinnacle Biologics Product Portfolio
  • 7.10 W.L. Gore & Associates Inc.
    • 7.10.1 W.L. Gore & Associates Inc. Business Overview
    • 7.10.2 W.L. Gore Associates & Inc. Financial Overview
    • 7.10.3 W.L. Gore Associates & Inc. Corporate Strategy
    • 7.10.4 W.L. Gore Associates & Inc. Product Portfolio

8. Qualitative Analysis of the Drug-Device Combination Market

  • 8.1 Porter's Five Forces Analysis of the Drug-Device Combination Market
  • 8.2 Rivalry among Competitors [High]
  • 8.3 Threat of New Entrants [Medium]
  • 8.4 Power of Suppliers [Low]
  • 8.5 Power of Buyers [Medium]
  • 8.6 Threat of Substitutes [Medium]

9. Conclusions

  • 9.1 Current Leading Drug-Device Combination Market Segments
    • 9.1.1 Leading Drug-Device Combination Products Companies
    • 9.1.2 Leading Regional Markets
    • 9.1.3 Emerging Drug-Device Combination Products Markets

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 2.1 Global Drug-Devices Combination Market Segmentation Overview, 2017
  • Figure 3.1 Global Drug-Device Combination Market by End-Users, 2016, (% Share)
  • Figure 3.2 Drug-Device Combination Submarkets, by End-Users, Forecast ($bn) 2016-2027
  • Figure 3.3 Hospital and Clinics Market Forecasts, by % AGR 2017-2027
  • Figure 3.4 Global Hospitals & Clinics Market by Region, 2016-2027
  • Figure 3.5 Global Hospitals & Clinics Market Share, by Region, (% Share) 2016-2027
  • Figure 3.6 Emergency Service Centers Submarkets Forecasts, by % AGR 2017-2027
  • Figure 3.7 Global Emergency Service Centers Market by Region, 2016-2027
  • Figure 3.8 Global Emergency Service Centers Market Share, by Region, (% Share) 2016-2027
  • Figure 3.9 Ambulatory Surgical Centers Submarkets Forecasts, by % AGR 2017-2027
  • Figure 3.10 Global Physician Offices Market by Region, 2016-2027
  • Figure 3.11 Global Physician Offices Market Share, by Region, (% Share) 2016-2027
  • Figure 3.12 Home Care Settings Submarkets Forecasts, by % AGR 2017-2027
  • Figure 3.13 Global Home Care Settings Market by Region, 2016-2027
  • Figure 3.14 Global Home Care Settings Market Share, by Region, (% Share) 2016-2027
  • Figure 4.1 Global Drug-Device Combination Market by Products, 2016, (% Share)
  • Figure 4.2 Drug-Device Combination Submarkets, by Products Type, Forecast ($bn) 2016-2027
  • Figure 4.3 Drug Eluting Stent Market Forecasts, by % AGR 2017-2027
  • Figure 4.4 Global Drug Eluting Stent Market by Region, 2016-2027
  • Figure 4.5 Global Drug Eluting Stent Market Share, by Region, (% Share) 2016-2027
  • Figure 4.6 Photosensitizers Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.7 Global Photosensitizers Market by Region, 2016-2027
  • Figure 4.8 Global Photosensitizers Market Share, by Region, (% Share) 2016-2027
  • Figure 4.9 Orthopedic Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.10 Global Orthopedic Products Market by Region, 2016-2027
  • Figure 4.11 Global Orthopedic Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.12 Infusion Pumps Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.13 Global Infusion Pumps Market by Region, 2016-2027
  • Figure 4.14 Global Infusion Pumps Market Share, by Region, (% Share) 2016-2027
  • Figure 4.15 Wound Care Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.16 Global Wound Care Products Market by Region, 2016-2027
  • Figure 4.17 Global Wound Care Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.18 Transmucosal Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.19 Global Transmucosal Products Market by Region, 2016-2027
  • Figure 4.20 Global Transmucosal Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.21 Transdermal Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.22 Global Transdermal Products Market by Region, 2016-2027
  • Figure 4.23 Global Transdermal Products Market Share, by Region, (% Share) 2016-2027
  • Figure 4.24 Other Combination Products Submarkets Forecasts, by % AGR 2017-2027
  • Figure 4.25 Global Other Combination Products Market by Region, 2016-2027
  • Figure 4.26 Global Other Combination Products Market Share, by Region, (% Share) 2016-2027
  • Figure 5.1 Regional Drug-Device Combination Market Forecasts ($bn), 2017-2027
  • Figure 5.2 Regional Drug-Device Combination Market Share (%), 2016
  • Figure 5.3 North American Drug-Devices Combination Market Share Analysis, by Country ($bn, AGR%), 2016
  • Figure 5.4 U.S. Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.5 Rest of North America Pharma Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.6 North American Drug-Device Combination Market Revenue Analysis, by Product ($bn, AGR%), 2016-2027
  • Figure 5.7 North American Cancer Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 5.8 European Pharma Clinical Trial Services Market Share Analysis, by Country ($bn, AGR%), 2016
  • Figure 5.9 France Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.10 Germany Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.11 U.K. Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.12 Spain Pharma Clinical Trial Services Market Forecasts ($bn), 2016-2027
  • Figure 5.13 Italy Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.14 Russia Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.15 Rest of Europe Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.16 European Drug-Device Combination Market Revenue Analysis, by Product ($bn, AGR%), 2016-2027
  • Figure 5.17 European Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 5.18 Asia-Pacific Drug-Device Combination Market Share Analysis, by Country ($bn, AGR%), 2016
  • Figure 5.19 China Drug-Device Market Forecasts ($bn), 2016-2027
  • Figure 5.20 India Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.21 Japan Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.22 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.23 Asia-Pacific Drug-Device Combination Market Revenue Analysis, by Products ($bn, AGR%), 2016-2027
  • Figure 5.24 Asia-Pacific Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 5.25 Rest of the World (RoW) Drug-Device Combination Market Share Analysis, by Country ($bn, AGR%), 2016-2027
  • Figure 5.26 Latin America Drug-Device Combination Market Forecasts ($mn), 2016-2027
  • Figure 5.27 Middle East and Africa Drug-Device Combination Market Forecasts ($bn), 2016-2027
  • Figure 5.28 RoW Drug-Devices Combination Market Revenue Analysis, by Products ($bn, AGR%), 2016-2027
  • Figure 5.29 RoW Drug-Device Combination Market Revenue Analysis, by End-Users ($bn, AGR%), 2016-2027
  • Figure 6.1 Market: Drivers and Restraints, 2017-2027
  • Figure 7.1 Medtronic 2016 Annual Revenue by Business Segments
  • Figure 7.2 Medtronic Annual Revenue 2012- 2016 ($mn)
  • Figure 7.3 Boston Scientific Corporation 2016 Annual Revenue by Business Segments
  • Figure 7.4 Boston Scientific Corporation Annual Revenue 2012- 2016 ($mn)
  • Figure 7.5 Stryker Corporation 2016 Annual Revenue by Business Segments
  • Figure 7.6 Stryker Corporation Annual Revenue 2012- 2016 ($mn)
  • Figure 7.7 Johnson & Johnson 2016 Annual Revenue by Business Segments
  • Figure 7.8 Johnson & Johnson Annual Revenue 2012- 2016 ($mn)
  • Figure 7.9 C.R. Bard Inc. 2016 Annual Revenue by Business Segments
  • Figure 7.10 C. R. Bard Inc. Annual Revenue 2012- 2016 ($mn)
  • Figure 7.11 Mylan Inc. 2016 Annual Revenue by Business Segments
  • Figure 7.12 Mylan Inc. Annual Revenue 2012- 2016 ($mn)
  • Figure 7.13 Terumo Corporation 2016 Annual Revenue by Business Segments
  • Figure 7.14 Terumo Corporation Annual Revenue 2012- 2016 ($mn)
  • Figure 8.1 Porter's Five Forces Analysis of the Drug-Device Combination Market, 2017-2027

List of Tables

  • Table 3.1 Drug-Device Combination Products Submarkets, by End-Users Forecast ($bn, CAGR%)
  • Table 3.2 Hospitals/Clinical Laboratories Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 3.3 Emergency Service Centers Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 3.4 Ambulatory Surgical Centers Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 3.5 Home Care Settings markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.1 Drug-Device Combination Submarkets, by Products Type Forecast ($bn, CAGR%)
  • Table 4.2 Drug Eluting Stent Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.3 Photosensitizers Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.4 Orthopedic Products markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.5 Infusion Pumps Markets, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.6 Wound Care Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.7 Transmucosal Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.8 Transdermal Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 4.9 Other Combination Products Market, by Region, Forecast ($bn, AGR%, CAGR%) 2016-2027
  • Table 5.1 Regional Drug-Devices Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.2 U.S. Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.3 Rest of North America Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.4 North American Drug-Device Combination Market Forecasts, by Products Type ($bn, AGR% CAGR%) 2016-2027
  • Table 5.5 North American Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 5.6 France Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.7 Germany Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.8 U.K. Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.9 Spain Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.10 Italy Pharma Clinical Trial Services Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.11 Russia Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.12 Rest of Europe Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.13 European Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
  • Table 5.14 European Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 5.15 China Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.16 India Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.17 Japan Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.18 Rest of Asia-Pacific (APAC) Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.19 Asia-Pacific Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
  • Table 5.20 Asia-Pacific Drug-Device Combination Market Forecasts, by End-Users ($bn, AGR% CAGR%) 2016-2027
  • Table 5.21 Latin America Drug-Device Combination Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.22 Middle East and Africa Pharma Clinical Trial Services Market Forecasts ($bn, AGR% CAGR%) 2016-2027
  • Table 5.23 RoW Pharma Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027
  • Table 5.24 RoW Drug-Device Combination Market Forecasts, by Products ($bn, AGR% CAGR%) 2016-2027

Companies Listed

  • Bayer
  • Baxter Healthcare
  • Boehringer Ingelheim
  • Boston Scientific Corporation
  • C.R. Bard Inc.
  • CeloNova Biosciences
  • Center for Biologics Evaluation and Research (CBER)
  • Center for Devices and Radiological Health (CDRH)
  • Center for Drug Evaluation and Research (CDER)
  • Ethicon Inc
  • Johnson & Johnson Co.
  • Meda
  • Medline Industries Inc.
  • Medtronic
  • Menarini Group
  • Merck KGaA
  • Mylan Inc.
  • National Institute of Health and Care Excellence (NICE)
  • NeuWave Medical, Inc.
  • Orion Corporation
  • PhysioControl International, Inc.
  • Pinnacle Biologics Inc.
  • Sage Products, LLC
  • Stryker Corporation
  • Synergetics
  • Terumo Corporation
  • Unites States Food and Drug Administration (FDA)
  • ViaCyte, Inc.
  • W. L. Gore & Associates, Inc.
  • World Health Organization (WHO)
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research